Suppr超能文献

牛因子VIII(抗血友病因子)的制备与特性

Preparation and properties of bovine factor VIII (antihemophilic factor).

作者信息

Vehar G A, Davie E W

出版信息

Biochemistry. 1980 Feb 5;19(3):401-10. doi: 10.1021/bi00544a001.

Abstract

Factor VIII has been purified approximately 300000-fold from bovine plasma by ammonium sulfate fractionation, glycine precipitation, DEAE-Sephadex column chromatography, sulfate--Sepharose column chromatography, Sephadex G-200 gel filtration, and factor X--Sepharose column chromatography. The highly purified preparation migrated as a triplet on sodium dodecyl sulfate/urea--polyacrylamide gel electrophoresis with apparent molecular weights of 93000, 88000, and 85000. The coagulant activity of the purified preparations was inhibited by antibodies raised in rabbits against either the purified factor VIII protein or a preparation of factor VIII/von Willebrand factor. Antibodies to the purified protein also inhibited the coagulant activity of factor VIII/von Willebrand factor preparations. The purified factor VIII contained no platelet-aggregating activity, as measured in human platelet-rich plasma. The purified preparation of factor VIII was required for the activation of factor X in the presence of factor IXa, calcium, and phospholipid. It was activated about 30-fold by thrombin or factor Xa plus calcium and phospholipid, and each of these reactions was accompanied by a change in the sodium dodecyl sulfate/urea--polyacrylamide gel electrophoresis pattern of the protein. Factor VIII was rapidly inactivated by bovine-activated protein C in a reaction requiring calcium and phospholipid. This reaction was also associated with a change in the sodium dodecyl sulfate/urea--polyacrylamide gel electrophoresis pattern of the highly purified protein. These experiments involving three highly specific serine proteases support the conclusion that the triplet observed on polyacrylamide gels is factor VIII.

摘要

通过硫酸铵分级分离、甘氨酸沉淀、二乙氨基乙基葡聚糖(DEAE - Sephadex)柱色谱法、硫酸化琼脂糖(sulfate--Sepharose)柱色谱法、葡聚糖凝胶G - 200凝胶过滤法以及因子X - 琼脂糖柱色谱法,已从牛血浆中纯化出约300000倍的因子VIII。高度纯化的制剂在十二烷基硫酸钠/尿素 - 聚丙烯酰胺凝胶电泳上呈现为三重态,其表观分子量分别为93000、88000和85000。纯化制剂的凝血活性被用纯化因子VIII蛋白或因子VIII/血管性血友病因子制剂免疫家兔产生的抗体所抑制。针对纯化蛋白的抗体也抑制因子VIII/血管性血友病因子制剂的凝血活性。在富含人血小板的血浆中检测发现,纯化的因子VIII不具有血小板聚集活性。在因子IXa、钙和磷脂存在的情况下,激活因子X需要纯化的因子VIII制剂。它被凝血酶或因子Xa加钙和磷脂激活约30倍,并且这些反应中的每一个都伴随着该蛋白在十二烷基硫酸钠/尿素 - 聚丙烯酰胺凝胶电泳图谱上发生变化。在需要钙和磷脂的反应中,因子VIII被牛活化蛋白C迅速灭活。该反应也与高度纯化蛋白在十二烷基硫酸钠/尿素 - 聚丙烯酰胺凝胶电泳图谱上的变化相关。这些涉及三种高度特异性丝氨酸蛋白酶的实验支持了聚丙烯酰胺凝胶上观察到的三重态是因子VIII的结论。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验